NCT05847985

Brief Summary

Lewy body diseases (LBDs) represents a group of neurodegenerative disorders characterized by the abnormal accumulation of aggregates of α-synuclein protein leading to the formation of Lewy bodies (LB) and Lewy neurites resulting in cell death. LBDs consists of two major clinical entities - Parkinson's disease (PD) and dementia with LB (DLB). Vast majority of patients with LBDs either already have mild cognitive impairment (MCI) at the time of the diagnosis or will develop it during the course of the disease. Language dysfunctions in LBDs patients with MCI are often unrecognized, which are difficult to treat, but even subtle changes might lead to impairment of social and occupational functioning with profound effect on their quality of lives. Current pharmacological or surgical strategies are effective for tackling the motor issues of LBDs with very limited effects on other symptoms such as language dysfunctions. Therefore, non-pharmacological approaches are gaining more attention. One of these non-pharmacological strategies is the use of noninvasive brain stimulation (NIBS) techniques that are able to modulate the brain functions with the effects on human nervous system plasticity. In this proposed project the investigators aim to first describe specific alterations in the language domain in LBDs patients with MCI as compared to healthy controls (HC) and identify the neural underpinnings of these changes using novel combination of advanced multimodal imaging techniques and various analytical methods. Secondly, the investigators aim to use NIBS as a supervised and individualized home-based therapeutical approach to tackle the language dysfunctions.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
May 2023Dec 2026

First Submitted

Initial submission to the registry

April 13, 2023

Completed
18 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 4, 2026

Status Verified

January 1, 2026

Enrollment Period

3.7 years

First QC Date

April 13, 2023

Last Update Submit

February 2, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • sentence comprehension performance - accuracy

    the investigators will study comprehension of syntactically complex sentences - accuracy in sentence comprehension task

    through study completion, an average of 1 year

  • sentence comprehension performance - reaction times

    the investigators will study comprehension of syntactically complex sentences - reaction times in sentence comprehension task

    through study completion, an average of 1 year

Secondary Outcomes (9)

  • relation of sentence comprehension performance to cognitive performance

    through study completion, an average of 1 year

  • The neural underpinning of sentence comprehension deficits - sentence comprehension fMRI task data

    through study completion, an average of 1 year

  • The neural underpinning of sentence comprehension deficits - resting state data

    through study completion, an average of 1 year

  • The neural underpinning of sentence comprehension deficits - structural MRI data

    through study completion, an average of 1 year

  • the long-term effects of repeated sessions of home-based tDCS on sentence comprehension - accuracy

    On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment

  • +4 more secondary outcomes

Study Arms (2)

Differences between LBDs patients and HC in regulation of language functions

NO INTERVENTION

In this study, 25 LBDs patients and 25 HC will undergo neuropsychological assessment, speech and writing recording, and MRI (structural T1 sequences, sentence comprehension fMRI task, neuromelanin-sensitive MRI sequence, and resting state measurement). The HC group will be matched to the LBDs patients with MCI for gender and age.

Long-term effects of repeated sessions of home-based tDCS delivered via telepractice

EXPERIMENTAL

The investigators will use a parallel-group, double-blinded, randomized, sham-stimulation-controlled design. Forty LBDs patients will be randomized into two parallel groups, n = 20 subjects in each arm. For the active group, the investigators will use the stimulation protocol with the anode over the left IFG (cathode over the right supraorbital area, 2mA, 20 minutes). Participants will undergo a baseline assessment (A0, as described in arm 1); 10 stimulation sessions (in a two-week period); a follow-up assessment immediately after tDCS treatment (A1), and follow-up assessments 8 weeks (A2) after the baseline assessment. Each assessment will consist of a brief neuropsychological assessment, speech and writing recording and MRI scanning.

Device: transcranial direct current stimulation (tDCS)

Interventions

tDCS using electric currents to modulate underlying neurons

Long-term effects of repeated sessions of home-based tDCS delivered via telepractice

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • right-handedness
  • Czech as their first language
  • age (60-80 years)
  • presence of PD-MCI (Litvan et al. 2012) or MCI-LB (McKeith et al. 2020) for LBD subjects

You may not qualify if:

  • cardio pacemaker
  • any MRI-incompatible metal in the body
  • epilepsy
  • any diagnosed psychiatric disorders
  • alcohol/drug abuse
  • for HC group the presence of LBDs or other neurodegenerative disorder or MCI/dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Masaryk University CEITEC

Brno, 62500, Czechia

RECRUITING

MeSH Terms

Conditions

Lewy Body Disease

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesDementiaMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2023

First Posted

May 8, 2023

Study Start

May 1, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 4, 2026

Record last verified: 2026-01

Locations